Morningstar Investor users sign in here.

Company Profile

  • Business description

    Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

  • Contact
  • Sector

    Healthcare

    Stock type

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    Employees

Bristol-Myers Squibb Co News & Analysis

stocks

What did Berkshire buy in Q3?

There were a few surprises in the wide-moat firm's 13-F filing.

Markets

Index
Last price
Change
% Change
All Ordinaries 8,243.30 19.10 -0.23%
CAC 40 7,586.35 46.36 -0.61%
DAX 40 18,498.72 92.17 -0.50%
Dow JONES (US) 40,211.72 210.82 0.53%
FTSE 100 8,155.27 27.69 -0.34%
HKSE 17,727.98 287.96 -1.60%
NASDAQ 18,472.57 74.12 0.40%
Nikkei 225 41,275.08 84.40 0.20%
NZX 50 Index 12,184.49 61.35 0.51%
S&P 500 5,631.22 15.87 0.28%
S&P/ASX 200 7,999.30 18.30 -0.23%
SSE Composite Index 2,976.30 2.29 0.08%

Market Movers

Name
Last price
Change
% Change
Droneshield Ltd DRO 2.02 0.58 -22.31%
Sayona Mining Ltd SYA 0.03 0.00 -2.94%
Red 5 Ltd RED 0.42 0.00 0.00%
Mirvac Group MGR 2.12 0.04 1.92%
Opthea Ltd OPT 0.38 0.01 -1.32%
Imugene Ltd IMU 0.06 0.00 -3.51%
Telstra Group Ltd TLS 3.83 0.01 -0.26%
Bellevue Gold Ltd BGL 1.87 0.07 -3.37%
Latin Resources Ltd LRS 0.16 0.01 -5.88%
Zip Co Ltd ZIP 1.61 0.03 1.90%